Inducible nitric oxide synthase deficiency ameliorates skeletal muscle insulin resistance but does not alter unexpected lower blood glucose levels after burn injury in C57BL/6 mice

Metabolism: Clinical and Experimental

Volumn 61, Issue 1, 2012, Pages 127-136

  Sugita, Michiko ^a,b   Sugita, Hiroki ^a,b   Kim, Minhye ^a   Mao, Ji ^a,b   Yasuda, Yoshikazu ^a,b   Habiro, Mayu ^a   Shinozaki, Shohei ^a,b   Yasuhara, Shingo ^a,b   Shimizu, Nobuyuki ^a,b   Martyn, J A Jeevendra ^a,b   Kaneki, Masao ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BODY SURFACE; BURN; CONFERENCE PAPER; CONTROLLED STUDY; EX VIVO STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INSULIN RESISTANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; BLOOD GLUCOSE; BURNS; GLUCOSE; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; TYROSINE;

EID: 82955162704     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2011.06.001     Document Type: Conference Paper

References (41)

1. Y.M. Yu, R.G. Tompkins, C.M. Ryan, and V.R. Young The metabolic basis of the increase of the increase in energy expenditure in severely burned patients JPEN J Parenter Enteral Nutr 23 1999 160 168 (Pubitemid 29218482)
2. D.W. Hart, S.E. Wolf, R. Mlcak, D.L. Chinkes, P.I. Ramzy, and M.K. Obeng Persistence of muscle catabolism after severe burn Surgery 128 2000 312 319 (Pubitemid 30622500)
3. D.W. Hart, S.E. Wolf, X.J. Zhang, D.L. Chinkes, M.C. Buffalo, and S.I. Matin Efficacy of a high-carbohydrate diet in catabolic illness Crit Care Med 29 2001 1318 1324 (Pubitemid 32641791)
4. K. Ipaktchi, and S. Arbabi Advances in burn critical care Crit Care Med 2006 34
5. U.A. Zifko Long-term outcome of critical illness polyneuropathy Muscle Nerve Suppl 9 2000 S49 52
6. P.A. Helm, G. Pandian, and E. Heck Neuromuscular problems in the burn patient: cause and prevention Arch Phys Med Rehabil 66 1985 451 453 (Pubitemid 15068213)
7. E. Hund Critical illness polyneuropathy Curr Opin Neurol 14 2001 649 653 (Pubitemid 32964586)
8. C.F. Bolton Critical illness polyneuropathy and myopathy Crit Care Med 29 2001 2388 2390 (Pubitemid 34038177)
9. P.Y. Chang, H. Benecke, Y. Le Marchand-Brustel, J. Lawitts, and D.E. Moller Expression of a dominant-negative mutant human insulin receptor in the muscle of transgenic mice J Biol Chem 269 1994 16034 16040 (Pubitemid 24209288)
10. D. Le Roith, H. Kim, A.M. Fernandez, and D. Accili Inactivation of muscle insulin and IGF-I receptors and insulin responsiveness Curr Opin Clin Nutr Metab Care 5 2002 371 375 (Pubitemid 40684657)
11. J.M. Agati, D. Yeagley, and P.G. Quinn Assessment of the roles of mitogen-activated protein kinase, phosphatidylinositol 3-kinase, protein kinase B, and protein kinase C in insulin inhibition of cAMP-induced phosphoenolpyruvate carboxykinase gene transcription J Biol Chem 273 1998 18751 18759 (Pubitemid 28366259)
12. H. Tamemoto, T. Kadowaki, K. Tobe, T. Yagi, H. Sakura, and T. Hayakawa Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1 Nature 372 1994 182 186 (Pubitemid 24347838)
13. N. Kubota, K. Tobe, Y. Terauchi, K. Eto, T. Yamauchi, and R. Suzuki Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia Diabetes 49 2000 1880 1889
14. Y. Kido, D.J. Burks, D. Withers, J.C. Bruning, C.R. Kahn, and M.F. White Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2 J Clin Invest 105 2000 199 205 (Pubitemid 30054359)
15. S.F. Previs, D.J. Withers, J.M. Ren, M.F. White, and G.I. Shulman Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo J Biol Chem 275 2000 38990 38994 (Pubitemid 32058910)
16. M.J. Saad, E. Araki, M. Miralpeix, P.L. Rothenberg, M.F. White, and C.R. Kahn Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance J Clin Invest 90 1992 1839 1849
17. T. Ikezu, T. Okamoto, K. Yonezawa, R.G. Tompkins, and J.A. Martyn Analysis of thermal injury-induced insulin resistance in rodents. Implication of postreceptor mechanisms J Biol Chem 272 1997 25289 25295 (Pubitemid 27415719)
18. E.A. Carter, D. Burks, A.J. Fischman, M. White, and R.G. Tompkins Insulin resistance in thermally-injured rats is associated with post-receptor alterations in skeletal muscle, liver and adipose tissue Int J Mol Med 14 2004 653 658
19. Q. Zhang, E.A. Carter, B.Y. Ma, M. White, A.J. Fischman, and R.G. Tompkins Molecular mechanism(s) of burn-induced insulin resistance in murine skeletal muscle: role of IRS phosphorylation Life Sci 77 2005 3068 3077 (Pubitemid 41430280)
20. G.S. Hotamisligil Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes Diabetes 54 Suppl 2 2005 S73 S78
21. M.C. Arkan, A.L. Hevener, F.R. Greten, S. Maeda, Z.W. Li, and J.M. Long IKK-beta links inflammation to obesity-induced insulin resistance Nat Med 11 2005 191 198 (Pubitemid 40321355)
22. G. Perseghin, K. Petersen, and G.I. Shulman Cellular mechanism of insulin resistance: potential links with inflammation Int J Obes Relat Metab Disord 27 Suppl 3 2003 S6 11
23. M.C. Lin, S. Ebihara, Q. El Dwairi, S.N. Hussain, L. Yang, and S.B. Gottfried Diaphragm sarcolemmal injury is induced by sepsis and alleviated by nitric oxide synthase inhibition Am J Respir Crit Care Med 158 1998 1656 1663
24. J.E. Barker, K.R. Knight, R. Romeo, J.V. Hurley, W.A. Morrison, and A.G. Stewart Targeted disruption of the nitric oxide synthase 2 gene protects against ischaemia/reperfusion injury to skeletal muscle J Pathol 194 2001 109 115
25. K. Mikawa, S.I. Kodama, K. Nishina, and H. Obara ONO-1714, a new inducible nitric oxide synthase inhibitor, attenuates diaphragmatic dysfunction associated with cerulein-induced pancreatitis in rats Crit Care Med 29 2001 1215 1221 (Pubitemid 32554337)
26. M. Perreault, and A. Marette Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle Nat Med 7 2001 1138 1143 (Pubitemid 33010023)
27. H. Sugita, M. Kaneki, E. Tokunaga, M. Sugita, C. Koike, and S. Yasuhara Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance Am J Physiol Endocrinol Metab 282 2002 E386 E394
28. H. Sugita, M. Fujimoto, T. Yasukawa, N. Shimizu, M. Sugita, and S. Yasuhara Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cells J Biol Chem 280 2005 14203 14211 (Pubitemid 40517322)
29. M.A. Carvalho-Filho, M. Ueno, S.M. Hirabara, A.B. Seabra, J.B. Carvalheira, and M.G. de Oliveira S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance Diabetes 54 2005 959 967 (Pubitemid 40446309)
30. M. Fujimoto, N. Shimizu, K. Kunii, J.A. Martyn, K. Ueki, and M. Kaneki A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice Diabetes 54 2005 1340 1348 (Pubitemid 40586662)
31. J.F. Tomera, K. Lilford, and J.A. Martyn Diaphragm acetylcholinesterase multimeric forms in mice in response to burn trauma J Burn Care Rehabil 14 1993 406 419 (Pubitemid 23246089)
32. H. Sugita, M. Kaneki, M. Sugita, T. Yasukawa, S. Yasuhara, and J.A. Martyn Burn injury impairs insulin-stimulated Akt/PKB activation in skeletal muscle Am J Physiol Endocrinol Metab 288 2005 E585 E591
33. T. Yasukawa, E. Tokunaga, H. Ota, H. Sugita, J.A. Martyn, and M. Kaneki S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance J Biol Chem 280 2005 7511 7518 (Pubitemid 40349643)
34. P.A. Hansen, E.A. Gulve, and J.O. Holloszy Suitability of 2-deoxyglucose for in vitro measurement of glucose transport activity in skeletal muscle J Appl Physiol 76 1994 979 985 (Pubitemid 24075652)
35. M.W. Pfaffl A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res 29 2001 45
36. S. Shinozaki, T. Chiba, K. Kokame, T. Miyata, M. Ai, and A. Kawakami Site-specific effect of estradiol on gene expression in the adipose tissue of ob/ob mice Horm Metab Res 39 2007 192 196 (Pubitemid 46580617)
37. M. Sekiya, J. Osuga, S. Nagashima, T. Ohshiro, M. Igarashi, and H. Okazaki Ablation of neutral cholesterol ester hydrolase 1 accelerates atherosclerosis Cell Metabolism 10 2009 219 228
38. G. van den Berghe, P. Wouters, F. Weekers, C. Verwaest, F. Bruyninckx, and M. Schetz Intensive insulin therapy in the critically ill patients N Engl J Med 345 2001 1359 1367
39. A.A. Bonab, E.A. Carter, K. Paul, M. Kaneki, Y.M. Yu, and R.G. Tompkins Effect of simvastatin on burn-induced alterations in tissue specific glucose metabolism: implications for burn associated insulin resistance Int J Mol Med 26 2010 311 316
40. K.M. Shakir, and R.M. Amin Endocrine crises. Hypoglycemia Crit Care Clin 7 1991 75 87
41. K.F. Fischer, J.A. Lees, and J.H. Newman Hypoglycemia in hospitalized patients. Causes and outcomes N Engl J Med 315 1986 1245 1250 (Pubitemid 17049682)